Acinetobacter baumannii has become a major concern for scientific attention due to
extensive antimicrobial resistance. This resistance causes an increase in mortality rate …

Carbapenem-resistant Acinetobacter baumannii (CRAB) causes colonization and infection
predominantly in hospitalized patients. Distinction between the two is a challenge. When …

The most recent European guidelines and task force reports on hospital-acquired
pneumonia (HAP) and ventilator-associated pneumonia (VAP) were published almost 10 …

Acinetobacter baumannii (A. baumannii) is undoubtedly one of the most successful
pathogens in the modern healthcare system. With invasive procedures, antibiotic use and …

Acinetobacter baumannii is an opportunistic bacterial pathogen primarily associated with
hospital-acquired infections. The recent increase in incidence, largely associated with …

Of all the ESKAPE pathogens, carbapenem-resistant and multidrug-resistant Acinetobacter
baumannii is the leading cause of hospital-acquired and ventilator-associated pneumonia …

Acinetobacter baumannii has emerged as a highly troublesome pathogen for many
institutions globally. As a consequence of its immense ability to acquire or upregulate …

Acinetobacter baumannii is an opportunistic pathogen of increasing importance due to its
propensity for intractable multidrug-resistant infections in hospitals. All clinical isolates …

Quantifying the benefit of early antibiotic treatment is crucial for decision making and can be
assessed only in observational studies. We performed a systematic review of prospective …

Multidrug-resistant Acinetobacter baumannii is recognized to be among the most difficult
antimicrobial-resistant gram-negative bacilli to control and treat. Increasing antimicrobial …